(Q30453680)

21 June 2017

title

Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca(2+) influx and induces streamers (English)

1 reference

21 June 2017

1 reference

P Todd Stukenberg

4

0 references

author name string

Paul V Beum

1

1 reference

21 June 2017

Margaret A Lindorfer

2

1 reference

21 June 2017

Elizabeth M Peek

3

1 reference

21 June 2017

Michel de Weers

5

1 reference

21 June 2017

Frank J Beurskens

6

1 reference

21 June 2017

Paul W H I Parren

7

1 reference

21 June 2017

Jan G J van de Winkel

8

1 reference

21 June 2017

Ronald P Taylor

9

1 reference

21 June 2017

language of work or name

English

0 references

publication date

4 July 2011

1 reference

European Journal of Immunology

21 June 2017

published in

1 reference

21 June 2017

volume

41

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

2436-2446

1 reference

Complement and its role in innate and adaptive immune responses

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Therapeutic potential of complement modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Complement: a key system for immune surveillance and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

The killer molecule of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Intracellular Ca2+ and cell injury: a paradoxical role of Ca2+ in complement membrane attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Growth and shape transformations of giant phospholipid vesicles upon interaction with an aqueous oleic acid suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Nanotubular highways for intercellular organelle transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Rapid and extensive membrane reorganization by dendritic cells following exposure to bacteria revealed by high-resolution imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Cutting edge: Membrane nanotubes connect immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Cutting edge: Membrane nanotubes in vivo: a feature of MHC class II+ cells in the mouse cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Structure and elastic properties of tunneling nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Dendritic cell altered states: what role for calcium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

The mechanism of activation of the alternative pathway of complement by cell-bound C4b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Complement function in mAb-mediated cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Comparison between complement and melittin hemolysis: anti-melittin antibodies inhibit complement lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Dynamic properties of antigen uptake and communication between dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Rituximab inhibits B-cell receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

IL-4 induces protection of vascular endothelial cells against killing by complement and melittin through lipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry: role of actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

B-lymphocyte calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

High throughput screening for antibody induced complement-dependent cytotoxicity in early antibody discovery using homogeneous macroconfocal fluorescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Induction of neuron-like tubes and liposome networks by cooperative effect of gangliosides and phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

inferred from DOI database lookup

7 January 2021

based on heuristic

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041204

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.201041204

1 reference

21 June 2017

1 reference